NC State
BioResources
Abedinifar, F., F. Farnia, S. M., Hosseinihashemi, S. K., Jalaligoldeh, A., Arabahmadi, S., and Mahdavi, M. (2020). "Design and synthesis of new benzofuran-1,2,3-triazole hybrid preservatives and the evaluation of their antifungal potential against white and brown-rot fungi," BioRes. 15(4), 7828-7843.

Abstract

A series of novel benzofuran-1,2,3-triazole hybrids were synthesized and investigated as fungicidal preservatives. The compounds were evaluated for their antifungal potential against white-rot (Trametes versicolor), dry brown-rot (Poria placenta), and wet brown-rot (Coniophora puteana and Gloeophyllum trabeum) fungi, at different concentrations (500 ppm and 1000 ppm). The tests of the final products (8a, 8b, 8c, 8d, 8e, 8f, and 8g) demonstrated that compound N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8f) at a concentration of 500 ppm was the most active against wet brown-rot C. puteana (23.86% inhibition) and G. trabeum (47.16% inhibition) fungi. However, testing demonstrated that compounds 8a, 8b, 8c, 8d, and 8g at a concentration of 500 ppm did not exhibit acceptable antifungal effects against white-rot T. versicolor and dry brown-rot P. placenta fungi.


Download PDF

Full Article

Design and Synthesis of New Benzofuran-1,2,3-Triazole Hybrid Preservatives and the Evaluation of Their Antifungal Potential Against White and Brown-Rot Fungi

Fahimeh Abedinifar,a S. Morteza F. Farnia,a,* Seyyed Khalil Hosseinihashemi,b,* Abbas Jalaligoldeh,c Shahrbanoo Arabahmadi,d and Mohammad Mahdavi e

A series of novel benzofuran-1,2,3-triazole hybrids were synthesized and investigated as fungicidal preservatives. The compounds were evaluated for their antifungal potential against white-rot (Trametes versicolor), dry brown-rot (Poria placenta), and wet brown-rot (Coniophora puteana and Gloeophyllum trabeum) fungi, at different concentrations (500 ppm and 1000 ppm). The tests of the final products (8a, 8b, 8c, 8d, 8e, 8f, and 8g) demonstrated that compound N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8f) at a concentration of 500 ppm was the most active against wet brown-rot C. puteana (23.86% inhibition) and G. trabeum (47.16% inhibition) fungi. However, testing demonstrated that compounds 8a, 8b, 8c, 8d, and 8g at a concentration of 500 ppm did not exhibit acceptable antifungal effects against white-rot T. versicolor and dry brown-rot P. placenta fungi.

Keywords: Triazoles; Synthesis; Antifungal activity; White and brown-rot fungi

Contact information: a: Department of Chemistry, College of Science, University of Tehran, Tehran, Iran; b: Department of Wood Science and Paper Technology, Karaj Branch, Islamic Azad University, Karaj, Iran; c: Department of Horticulture, Karaj Branch, Islamic Azad University, Karaj, Iran; d: Department of Chemistry, University of Mazandaran, P. O. Box: 47416-95447, Babolsar, Iran; e: Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Science Institute, Tehran University of Medical Sciences, Tehran, Iran; *Corresponding authors: mfarnia@gmail.com and hashemi@kiau.ac.ir

GRAPHICAL ABSTRACT

INTRODUCTION

Carbamates, creosotes, isothiazolones, quaternary ammonium compounds, sulfamides, and triazoles are the main classes of metal-free organic fungicides used for wood protection (Reinprecht 2010). Many of these preservatives are effective against a specific class of microorganism; however, synergistic effects have been reported for a group of triazole fungicides, which help overcome this selectivity (Bauschhaus and Valcke 1995; Christen et al. 2014). Furthermore, triazoles have an added advantage of exhibiting high antifungal activity in both organic solvent- and water-based formulations (Bruns et al. 2005).

Triazole fungicides have great importance in agriculture and medicine and are commonly used in two categories: (1) triazole antifungal drugs, e.g., fluconazole, voriconazole, isavuconazole, itraconazole, etc., and (2) triazole plant protection fungicides, e.g., tebuconazole, triadimefon, triadimenol, paclobutrazol, and flutriafol. The two triazole ring isomers, 1,2,3-triazole and 1,2,4-triazole, are found in both plant protection fungicides and the others antifungal drugs, respectively (Carisse 2010).

Propiconazole, tebuconazole, and azaconazole are well known synthetic fungicides that are commonly used in commercial formulations for wood preservation against all types of wood-rotting fungi (Wüstenhöfer et al. 1993). However, 1,2,4-triazoles have additional benefits of having a low toxicity to animals and being environmentally stable (Bakhsous et al. 2006). Propiconazole, tebuconazole, and chlorothalonile have shown inhibitory activity of 49.3%, 40.4%, and 7.1%, respectively, against the growth of T. versicolor fungus at 450 ppm (Hosseinihashemi et al. 2016a, Nazari and Hosseinihashemi 2017a; Nazari and Hosseinihashemi 2017b).

Shi et al. (2014) studied the synthesis and in vitro activity of 1-((benzofuran-2-yl)methyl)-1H triazole derivatives against a panel of five different human tumor cell lines and showed that benzotriazole, i.e., a 1,2,3-triazole ring with a substitution of the triazolyl-3-position with a naphthylacyl, 4-bromophenacyl, or 4-methylbenzyl group, could be crucial for promoting cytotoxic activity. Likewise, some of the studied compounds were found most potent with selectively against HL-60, SMMC-7721, and MCF-7 cell lines, respective to the above substitutions, and in particular, compound 20 was selective against the HL-60 and A549 cell lines with IC50 values of 0.62 µM and 1.60 µM.

A series of benzofuran-triazole hybrids were designed and synthesized by Liang et al. (2016), and the in vitro antifungal activity of the final compounds were evaluated using the microdilution broth method against five strains of pathogenic fungi. This study indicated that the target compounds exhibited moderate to satisfactory activity.

Some representative 1,2,3-triazole derivatives with antifungal activity are shown in Fig. 1 (Liang et al. 2016).

Fig. 1. Representative 1,2,3-triazole derivatives with antifungal activity

Recently, the 1,2,3-triazole scaffold became popular prominent fragment with the emergence of click chemistry. The 1,2,3-triazole-containing compounds have been reported to possess a variety of biological activities (Giffin et al. 2008; Weide et al. 2010; Xu et al. 2013; Kumar et al. 2014; Mohammadi-Khanaposhtani et al. 2015), especially as antifungal agents (Lima-Neto et al. 2012; Dai et al. 2015; Kamal et al. 2015). Furthermore, hybridizations of the 1,2,3-triazole moiety with other antifungal agents were reported (Giffin et al. 2008).

Reports by Hosseinihashemi et al. (2020), in regards to the effects of new benzofuran-1,3,4-oxadiazole hybrids on the inhibition of mycelial growth in wood-degrading fungi, showed that most of the compounds at 500 ppm concentration did not exhibit acceptable antifungal effects, but they had better antifungal activity at 1000 ppm concentration. Compounds 5a, 5c, and 5i at a concentration of 1000 ppm showed inhibition percentages of 14.6%, 23.0%, and 14.7%, respectively, against the growth of P. placenta and C. puteana. Among the tested compounds, 2-(benzofuran-2-yl)-5-((2,6-difluorobenzyl)thio)-1,3,4-oxadiazole (5h) hybrid was the most active one.

It is unclear whether such fungi (P. placenta and C. puteana) have a generic ability to degrade pesticides, and whether similar degradative abilities are ubiquitous among white-rot fungi (Bending et al. 2002).

Triazole fungicides, e.g., propiconazole and tebuconazole, inhibit the C14 demethylation step in the fungal ergosterol biosynthesis as demethylation inhibitors (DMIs) and thereby interfere with the basic metabolism of the fungal cell walls and contents (Copping et al. 1984).

Encouraged by the above results, the authors attempted to design and synthesize a series of new benzofuran-1,2,3-triazole hybrids to evaluate the in vitro antifungal activity against wood-deterioration fungi.

EXPERIMENTAL

Preparation of Synthesized Materials

All chemical compounds were purchased from Merck (Darmstadt, Germany), Sigma-Aldrich (Darmstadt, Germany), and Acros Chemical (Schwerte, Germany) and used without further purification.

Synthesis of ethyl benzofuran-2-carboxylates (2)

A mixture of 2-hydroxybenzaldehydes (1) (0.05 mol), ethyl bromoacetate (0.05 mol), anhydrous potassium carbonate (0.075 mol), and dried dimethylformamide (DMF) (70 mL) was heated at 90 °C for 4 h. This solution was decanted into ice water and the precipitate was filtered off and washed with cold water to afford ethyl benzofuran-2-carboxylate as cream powder (yield: 75%; M. p. 32 °C).

Synthesis of benzofuran-2-carboxylic acids (3)

Ethyl-1-benzofuran-2-carboxylate (2) (1 mmol) containing ethanol was added to water (at a 2 to 1 ratio, 30 mL) and potassium hydroxide (2 mmol); this mixture was refluxed for 2 h. The reaction was monitored via thin layer chromatography (TLC). After the reaction was completed, the reaction mixture was decanted into ice water and extracted with ethyl acetate. The ethyl acetate layer was separated, dried, and evaporated under vacuum to yield benzofuran-2-carboxylic acid (3) as a white crystal (yield: 85%; M. p. 190 °C).

Synthesis of N-(prop-2-ynyl)benzofuran-2-carboxamides (5)

A mixture of benzofuran-2-carboxylic acid (3) (1.5 mmol), HOBt (1.7 mmol), and EDC.HCl (1.7 mmol) in dried acetonitrile (10 mL) was stirred for 30 min at ambient temperature. Propargylamine (1.8 mmol) was added and the mixture was stirred for 24 h to 48 h. After the reaction was completed (checked via TLC), the crude product was extracted with chloroform, a citric acid solution (10%), and sodium hydrogen carbonate (10%). The organic layer was separated, dried, and evaporated under a vacuum to yield N-(prop-2-ynyl)benzofuran-2-carboxamides as a cream powder (5) (yield: 78%, M. p. 160.1-164 °C.

General procedure for the synthesis of product 8a-g

Triethylamine (1 mmol) and H2O/t-BuOH (1:1) (5 mL) were added to a mixture of benzyl bromide (6) (1.3 mmol) and sodium azide (1 mmol) and stirred for 1 h at room temperature. After that, N-(prop-2-yn-1-yl)benzofuran-2-carboxamide (5) (1 mmol), sodium ascorbate, and CuSO4 .5H2O (7 mol%) were added to the reaction mixture and stirred at room temperature for 24 h to 48 h. Then, the reaction mixture was diluted with cold water and poured into crushed ice and precipitated products 8a, 8b, 8c, 8d, 8e, and 8g were filtered off, washed with water, and purified via recrystallization in ethanol.

The proposed procedure for the synthesis of designed compounds 8a through 8g is depicted in Fig. 2.

Fig. 2. Synthesis of benzofuran-1,2,3-triazole hybrids: (a) Ethyl bromoacetate, K2CO3, Dry DMF, 90 °C, 4 h to 6 h; (b) KOH, Ethanol: H2O (2 to 1 ratio), reflux; (c) HOBT, EDC.HCl, dry CH3CN, room temperature (r.t.), 24 h to 48 h; (d) NaN3, NEt3, H2O/t-BuOH (1 to 1 ratio), 1 h, r.t.; and (e) CuSO4 .5H2O, Sodium ascorbate, r.t., 24 h to 48 h

N-((1-(2-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8a)

White powder; 0.298 g, Yield: (86%); M. p. 147-150 ºC. IR (KBr) (νmax/cm–1): 3421 (NH), 1659 (CO). 1H NMR (500 MHz, CDCl3): δ 2.30 (3H, s, Me) , 4.75 (2H, bs), 5.51 (2H, s), 7.15 (1H, bs) , 7.21 (2H, d, J = 6 Hz), 7.26 to 7.28 (2H, m), 7.39 (2H, t, J = 6 Hz), 7.44 to 7.47 (2H, m), 7.64 (1H, d, J = 6 Hz). 13C NMR (125 MHz, DMSO-d6): δ 18.60, 34.34, 50.80, 109.44, 109.57, 111.73, 122.71, 123.05, 123.19, 123.71, 126.17, 126.85, 128.25, 128.69, 130.35, 136.27, 144.79, 148.88, 154.17, and 158.05. Combustion elemental analysis (Anal.) calculated (Calcd) for C20H18N4O2: C, 69.35; H, 5.24; N, 16.17. Found: C, 69.48; H, 5.51; N, 16.04.

N-((1-(2-chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8b)

White powder; 0.319 g, Yield: (87%); M. p. 149-152 ºC. IR (KBr) (νmax/cm–1): 3417 (NH), 1656 (CO). 1H NMR (500 MHz, CDCl3): δ 4.79 (2H, bs) , 5.67 (2H s) , 7.20 (1H, bs), 7.26 to 7.33 (3H, m) , 7.40 (1H, s), 7.43 (1H, t, J = 7.5 Hz), 7.47 (1H, d, J = 5.8 Hz), 7.49 (1H, s), 7.80 (1H, bs, NH-). 13C NMR (125 MHz, DMSO-d6): δ 34.69, 51.43, 110.54, 111.78, 122.62, 123.64, 126.93, 127.43, 127.55, 129.92, 130.26, 130.36, 132.21, 144.63, 148.32, 154.72, and 158.84. EI-MS, m/z: 366.2 (Calcd for C19H15ClN4O2: 366.81). Anal. Calcd for C19H15ClN4O2: C, 62.21; H, 4.12; N, 15.27. Found: C, 62.13; H, 4.02; N, 15.46.

N-((1-(3-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8c)

White powder; 0.283 g, Yield: 82%; M. p. 174.5-176.3 ºC. IR (KBr) (νmax/cm–1): 3420 (NH), 1655 (CO). 1H NMR (500 MHz, CDCl3): δ 2.32 (3H, s, Me), 4.75 (2H, bs), 5.46 (2H, s), 7.07 to 7.09 (2H, m), 7.15 (1H, d, J = 8 Hz), 7.23-7.28 (2H, m), 7.38 (1H, t, J = 7.5 Hz), 7,44 (1H, d, J = 6 Hz), 7.45 (1H, s), 7.58 (1H, bs, NH-), 7.63 (1H, d, J = 7.5 Hz). 13C NMR (125 MHz, CDCl3): δ 21.28, 34.80, 54.32, 110.50, 111.82, 122.63, 123.67, 125.23, 126.93, 127.49, 128.88, 129.00, 120.55, 134.36, 138.96, 148.47, 154.80, and 158.92. EI-MS, m/z: 346.3 (Calcd for C20H18N4O2: 346.3). Anal. Calcd for C20H18N4O2: C, 69.35; H, 5.24; N, 16.17. Found: C, 69.53; H, 5.11; N, 16.28.

N-((1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8d)

White powder; 0.309 g, Yield: 86%; M. p. 127-128 ºC. IR (KBr) (νmax/cm–1): 3462 (NH), 1657 (CO). 1H NMR (500 MHz, CDCl3): δ 3.73 (3H, s, -OMe), 4.71 (2H, d, J = 5.3 Hz), 5.47 (2H, s), 6.78 (1H, s), 6.82 to 6.85 (2H, m), 7.24 (1H, t, J = 7.7 Hz), 7.26 (1H, s), 7.36 (1H, t, J = 7.7 Hz), 7.41 (1H, d, J = 6.6 Hz), 7.42 (1H, s), 7.53 (1H, bs, NH), 7.59 to 7.62 (2H, d, J = 8 Hz). 13C NMR (125 MHz, CDCl3): δ 34.68, 54.27, 55.24, 110.57, 111.79, 113.74, 114.19, 120.29, 122.62, 123.64, 126.90, 126.94, 127.40, 130.18, 135.75, 148.28, 154.70, 158.85, and 160.02. EI-MS, m/z: 362.3 (Calcd for C20H18N4O3: 362.3). Anal. Calcd for C20H18N4O3: C, 66.29; H, 5.01; N, 15.46. Found: C, 66.37; H, 5.10; N, 15.39.

N-((1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8e)

White powder; 0.297 g, Yield: 81%; M. p. 179-181 ºC. IR (KBr) (νmax/cm–1): 3457 (NH), 1656 (CO). 1H NMR (500 MHz, CDCl3): δ 3.80 (3H, s, -OMe), 4.74 (2H, bs), 5.44 (2H, s), 6.88 (2H, d, = 8.5 Hz), 7.23 (2H, d, J = 8.5 Hz), 7.26 to 7.28 (2H, m), 7.41 (1H, t, = 7.5 Hz), 7.45 (1H, s), 7.46 (1H, d, = 7.5 Hz), 7.60 (1H, bs, -NH), 7.65 (1H, d, = 7.5Hz). 13C NMR (125 MHz, CDCl3): δ 34.55, 54.43, 55.30, 110.65, 111.81, 114.47, 122.64, 123.67, 126.31, 126.97, 127.44, 129.79, 133.10, 137.11, 139.10, 146.10, 148.33, 154.76, 158.82, and 160.02. Anal. Calcd for C20H18N4O3: C, 66.29; H, 5.01; N, 15.46. Found: C, 66.18; H, 5.16; N, 15.25.

N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8f)

Pale yellow powder; 0.301 g, Yield: 86%; M. p. 173-175 ºC. 1H NMR (500 MHz, CDCl3): δ 4.70 (2H, bs), 5.48 (2H, s), 7.06 (2H, t, J = 8 Hz), 7.26 to 7.30 (4H, m), 7.41 (1H, m), 7.46 to 7.49 (2H, m), 7.66 (1H, m). 13C NMR (125 MHz, CDCl3): δ 34.39, 54.43, 110.72, 111.80, 116.02, 116.19, 122.67, 123.71, and 127.01, 127.44, 130.08. Anal. Calcd for C19H15FN4O2: C, 65.14; H, 4.32; N, 15.99. Found: C, 65.23; H, 4.21; N, 16.08.

N-((1-(4-bromobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8g)

White powder; 0.370 g, Yield: 90%; M. p. 197-199 ºC. IR (KBr) (νmax/cm–1): 3411 (NH), 1655 (CO). 1H NMR (500 MHz, CDCl3): δ 4.76 (2H, bs), 5.47 (2H, s), 7.15 (2H, d, J = 8 Hz), 7.26 (1H, s), 7.29 (1H, t, J = 7.5 Hz), 7.42 (2H, m), 7.42 (1H, t, J = 7.5 Hz), 7.46 to 7.51 (4H, m), 7.66 (1H, d, J = 7.7 Hz). EI-MS, m/z: 410.2 (Calcd for C19H15BrN4O2: 411.2). Anal. Calcd for C19H15BrN4O2: C, 55.49; H, 3.68; N, 13.62. Fund: C, 55.38; H, 3.79; N, 13.53.

Antifungal Activity Evaluation

To evaluate the antifungal properties of various compounds, 12 mg of each of the synthetic fungicides (dry powder) was dissolved into 12 mL of methanol (MeOH) (Merck, Darmstadt, Germany), used as a solvent. The solution was passed by syringe from a 0.45 μm Microsolve filter and poured into a sterile glass vial. Approximately 25 mL of the sterilized medium was placed in an autoclave for 20 min at 120 °C and 1.2 atm, and then it was poured into Petri plates. Then 25 μL of the solution was added via micro-sampler at various concentrations (500 ppm and 1000 ppm on four antibiogram discs) to medium containing malt extract agar (MEA) for microbiology (Merck KgaA 64271 Darmstadt, Germany), pH value: 5.6 (48 g/L, H2O, 22 °C) after autoclaving and were each poured into one of the Petri plates.

Ketoconazole, as the representative synthetic fungicide (at 500 ppm and 1000 ppm concentrations), was used as the positive control due to its inhibitory effects against radial growth of three wood-degrading fungi, i.e.T. versicolorP. placenta, and C. puteana. Methanol was selected as the negative control to confirm that there was no inhibitory effect (Teoh et al. 2015; Hosseinihashemi et al. 2020).

The plates were cooled in a sterile hood and inoculated with 0.50 cm plugs of Trametes versicolorPoria placentaConiophora puteana, and Gloeophyllum trabeum fungi mycelia, which were introduced into the center of the Petri plate. The inoculated plates were incubated at 23 °C and 75% relative humidity without light. Four replicate antibiogram discs and one plate were used per treatment. The fungi were also grown on plates with non-compound MEA (i.e., with methanol) as a negative control. The percentage of fungal mycelial growth was plotted against the compound concentration, and the toxicity level was determined by the compound concentration. In other words, the fungal growth was monitored daily by measuring the percentage of area that was covered by fungus in the test plates until one day prior to complete coverage of Petri plate, similar to reported methods (Hosseinihashemi et al. 2016a, 2016b; Hosseinihashemi et al. 2020).

The colony fungal growth (shown by radius) was measured, and the percentage inhibition was calculated according to Eq 1.,

Percentage inhibition = [(CT)/C] x 100 (1)

where C= is the average colony radius (mm) of the negative control and T= is the average colony radius (mm) of the test plate.

Chemistry Methods and Procedures

The progress of the reaction was monitored via thin layer chromatography (silica gel 250 micron, F254 plates, Merck, Darmstadt, Germany). Melting points were determined using an Electrothermal 9100 apparatus. The IR spectra were recorded with a Shimadzu IR-460 spectrometer. The 1H and 13C NMR spectra were measured with a Bruker DRX-500 AVANCE (at 500.1 MHz and 125.8 MHz) instrument. The mass spectra were recorded with an Agilent Technology (HP) mass spectrometer, which operated at an ionization potential of 20 eV. The elemental analysis was performed with an ElementarAnalysen system GmbH VarioEL (CHN mode).

Statistical analysis

Percentage inhibition was calculated and an analysis of variance for the different treatments was conducted using Duncan’s test.

RESULTS AND DISCUSSION

Chemistry

Figure 2 describes the condensation reaction between salicylaldehyde (1) and ethyl bromoacetate in the presence of K2CO3, which afforded ethyl benzofuran-2-carboxylates (2). The subsequent hydrolysis in aqueous ethanol/KOH yielded benzofuran-2-carboxylic acid (3). The propargylation of the latter compounds with propargyl amine (4) in the presence of hydroxybenzotriazole (HOBt) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC.HCl) as coupling agents resulted in compound (5). The N-(prop-2-ynyl)benzofuran-2-carboxamide (5) compounds were used for the click reaction. For this purpose, various benzyl bromide derivatives (6) and sodium azide, reacted in the presence of Et3N in H2O/t-BuOH at room temperature. Then, N-(prop-2-ynyl)benzofuran-2-carboxamide (5), CuSO4 .5H2O, and sodium ascorbate were added to the freshly prepared azide derivatives (7) and the reaction was continued at room temperature for 8 h to 12 h to give the corresponding products 8a through 8g with sufficient yields, i.e., 80% to 90% (as shown in Fig. 3).

Fig. 3. Final compounds: 8a, 8b, 8c, 8d, 8e, 8f, and 8g

Activity Evaluation of Antifungal Compounds Against Fungi

The in vitro antifungal activity of the target compounds was measured via the malt extract agar disk diffusion method with ketoconazole as the control fungicide or drug. The results are summarized in Table 1 and Fig. 4. The potential of synthetic compounds 8a, 8b, 8c, 8d, 8e, 8f, and 8g as wood preservatives were evaluated by determining the percentage of mycelial growth inhibition against the four tested wood-degrading fungi, Trametes versicolorPoria placentaConiophora puteana, and Gloeophyllum trabeum, at 500 ppm and 1000 ppm. Methanol and ketoconazole were used as a negative and positive control, respectively.

Table 1. Mean ± (Std.) Values of the % Mycelial Growth Inhibition of Four Tested Wood-Degrading Fungi by the Seven Novel Synthetic Fungicide Preservatives and Ketoconazole at Two Concentrations per 25 cm3 of Malt Extract Agar (in One Day Prior to Complete Coverage by Fungus in the Negative Control Plates)

8a: N-((1-(2-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; 8b: N-((1-(2-chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; 8c: N-((1-(3-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; 8d: N-((1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; 8e: N-((1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; 8f: N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; 8g: N-((1-(4-bromobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide; C (+): Ketoconazole

Fig. 4. Percentage of mycelial growth inhibited by synthetic fungicides

Statistically, there was a significant difference between the compounds and their concentrations on the percentage of mycelial growth inhibition of wood-degrading fungi (Table 2).

Table 2. Univariate Test Results for Percentage of Mycelial Growth Inhibition of the Four Tested Wood-Degrading Fungi by the Seven Novel Synthetic Fungicide Preservatives and Ketoconazole at Two Concentrations per 25 cm3 of Malt Extract Agar (in One Day Prior to Complete Coverage by Fungus in the Negative Control Plates)

According to the results, some of the target compounds exhibited acceptable antifungal activity at 500 ppm and 1000 ppm. Compound 8c showed better antifungal activity at 1000 ppm against T. versicolor (with a percentage inhibition of 10.71%) in comparison to the other compounds with the exception of the positive control at all concentrations. In addition, compounds 8b, 8a, and 8d showed inhibition rates of 12.57%, 10.18%, and 10.18%, respectively, against P. placenta, which were more effective than the ketoconazole at 30 ppm, 500 ppm, and 1000 ppm. However, ketoconazole showed better antifungal activity at 60 ppm against P. placenta with a inhibition rate of 25.28%. At 1000 ppm, better antifungal activity against T. versicolor and P. placenta was observed for most of the synthetic compounds. Particularly, compounds 8c, 8f, 8e, and 8g exhibited inhibition rates of 10.23%, 17.61%, 11.93%, and 11.36%, respectively, against the growth of C. puteana fungus. The greatest antifungal activities were for compound 8c at 500 ppm and compound 8f at 500 ppm and 1000 ppm showing inhibition of 15.34%, 47.16%, and 15.91%, respectively, against G. trabeum. These two compounds were more effective than ketoconazol at 30 ppm and 60 ppm. However, ketoconazole showed better antifungal activity at 500 ppm and 1000 ppm against G. trabeum fungus with an inhibition rate of 64.78% and 65.34%, respectively.

The synthetic 1,2,3-triazole derivatives showed moderate control over the growth of fungi rather than their positive control for ketoconazole, at 30 ppm, 60 ppm, 500 ppm, and 1000 ppm concentrations. Among all the novel synthetic compounds, N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8f) was the most active antifungal agent against the mycelium growth of G. trabeum fungus.

The trends of the percentage inhibition of white-rot (T. versicolor) growth after 6 d (one day prior to complete coverage by fungus in the negative control plates) were shown in Fig. 5. As shown in Fig. 5, the compounds with greater and lower than 10% inhibition are indicated by solid and dashed lines, respectively. Among the synthesized compounds that inhibited the growth of T. versicolor, N-((1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8c) had the greatest performance, with an inhibition rate of 10.71% at a 1000 ppm concentration.

Fig. 5. Trends of the percentage inhibition of T. versicolor growth by different synthetic fungicides solutions with 500 ppm and 1000 ppm concentrations in 6 d (the 7th d was the final time)

Fig. 6. Trends of the percentage inhibition of P. placenta growth by different synthetic fungicides solutions with 500 ppm and 1000 ppm concentrations in 7 d (the 8th d was the final time)

Figure 6 illustrates the trends of percentage inhibition of dry brown-rot (P. placenta) growth after 7 d (one day prior to complete coverage by fungus in the negative control plates). In Fig. 6, the compounds above 0% to 10% of inhibition and above 10% of inhibition, were indicated by dashed and solid lines, respectively.

The most effective synthesized compounds that inhibited the growth of P. placenta were N-((1-(2-chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8b), with the position of 2-Cl substitution, N-((1-(2-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8a), with the position of 2-CH3 substitution, and N-((1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8d), with the position of 3-OCH3 substitution, at a concentration of 1000 ppm (12.57%, 10.18%, and 10.18%, respectively).

The trends of percentage inhibition of wet brown-rot (C. puteana) growth after 18 d (one day prior to complete coverage by fungus in the negative control plates) are shown in Fig. 7. As shown in Fig. 7, the compounds that had greater than 10% inhibition are indicated by solid lines. Among the novel synthesized compounds, N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8f) at a concentration of 500 ppm could inhibited the growth of C. puteana by 23.86%, which more effective than ketoconazole at the four various concentrations.

Figure 8 shows the trends of percentage inhibition of wet brown-rot (G. trabeum) growth after 11 d (one day prior to complete coverage by fungus in the negative control plates). As shown in Fig. 8, the compounds that had greater than 10% inhibition were indicated by solid lines. Three synthesized compounds showed high growth percentage inhibition amounts (15.34%, 15.91%, and 47.16%), with the compound with the highest inhibition value was N-((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)benzofuran-2-carboxamide (8f), at 500 ppm concentration.

Fig. 7. Trends of the percentage inhibition of C. puteana growth by different synthetic fungicides solutions with 500 ppm and 1000 ppm concentrations in 18 d (the 19th d was the final time)

Fig. 8. Trends of the percentage inhibition of G. trabeum growth by different synthetic fungicides solutions with 500 ppm and 1000 ppm concentrations in 11 d (the 12th d was the final time)

As shown in Fig. 8 and Fig. 9b, the growth of G. trabeum stopped after 6 d when tested with compound 8f, which at the final day of growth (12th d) reached a percentage of inhibition of 48.33%.